Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 104 institutions that hold shares in the stock, with a total of 50.7 Million shares, which have been reported (via 13F filing form) to have a value of $60.9 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,160,000
shares
|
$6.19 Million
0.03% of portfolio
|
Q4 2024
Reduced 9.05%
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Feb 13, 2025 Q4 2024 |
4,494,851
shares
|
$5.39 Million
11.45% of portfolio
|
Q3 2023
Added 22.76%
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
4,280,308
shares
|
$5.14 Million
0.97% of portfolio
|
Q4 2023
Added 17.1%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
3,972,318
shares
|
$4.77 Million
1.97% of portfolio
|
Q4 2024
Added 40.75%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,861,983
shares
|
$4.63 Million
0.43% of portfolio
|
Q4 2024
Added 1.55%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,343,193
shares
|
$4.01 Million
0.0% of portfolio
|
Q2 2024
Added 8.24%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,633,249
shares
|
$3.16 Million
0.0% of portfolio
|
Q4 2024
Added 0.34%
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
2,437,689
shares
|
$2.93 Million
0.48% of portfolio
|
Q4 2022
Reduced 0.27%
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,220,000
shares
|
$2.66 Million
0.12% of portfolio
|
Q4 2024
Reduced 46.3%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,882,274
shares
|
$2.26 Million
0.0% of portfolio
|
Q4 2024
Added 7.9%
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
1,562,500
shares
|
$1.88 Million
1.33% of portfolio
|
Q3 2023
New holding
|
|
Saturn V Capital Management LLC
Austin, TX |
Feb 14, 2025 Q4 2024 |
1,374,582
shares
|
$1.65 Million
1.49% of portfolio
|
Q4 2024
Added 0.42%
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
1,270,027
shares
|
$1.52 Million
2.63% of portfolio
|
Q3 2023
Added 6.28%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
1,191,140
shares
|
$1.43 Million
0.68% of portfolio
|
Q3 2024
Reduced 18.57%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,179,622
shares
|
$1.42 Million
0.0% of portfolio
|
Q4 2024
Added 0.72%
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,080,027
shares
|
$1.3 Million
1.28% of portfolio
|
Q4 2024
Reduced 3.57%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,007,455
shares
|
$1.21 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.09%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,003,124
shares
|
$1.2 Million
0.02% of portfolio
|
Q3 2024
Added 0.24%
|
|
Knott David M Jr
Syosset, NY |
Feb 12, 2025 Q4 2024 |
695,000
shares
|
$834,000
1.11% of portfolio
|
Q4 2024
Added 23.11%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
616,909
shares
|
$740,290
0.0% of portfolio
|
Q4 2024
Added 1144.77%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
504,670
shares
|
$605,604
0.0% of portfolio
|
Q4 2024
Added 13.12%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
450,764
shares
|
$540,916
0.0% of portfolio
|
Q4 2024
Added 2.72%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
421,399
shares
|
$505,678
0.0% of portfolio
|
Q4 2024
Added 155.7%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
252,722
shares
|
$303,266
0.0% of portfolio
|
Q4 2024
Reduced 43.5%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
250,229
shares
|
$300,274
0.0% of portfolio
|
Q4 2024
Added 23.43%
|